Tobacco use is one of the strongest cancer-causing agents, and cigarette smoking remains the leading cause of preventable deaths in the United States. Tobacco use is also the world's leading cause of preventable death, with global mortality projected to rise from 5.4 million in 2005 to 8.3 million in 2030. This challenge has stimulated a substantial and innovative public health response, both at state and federal level and increasingly internationally. Notwithstanding such progress, developments in the global political economy, including in trade and global governance, continue to generate challenges for public health. Agreements designed to promote trade, the practices of international finance organizations and broader trends in national and supranational governance can each conflict with public health priorities. This is evident in the arbitration claim recently brought to the World Trade Organization (WTO) by Indonesia against Section 907 of the Family Smoking Prevention and Tobacco Control Act. Such conflicts have the potential to undermine progress in tobacco control. Tobacco document research (TDR) to date has dramatically increased understanding of industry strategies to undermine specific tobacco control policies, largely at national level. Yet understanding remains limited of how tobacco companies advance their global interests through broader strategies of engagement with trade and governance agendas, including via influence over economic and foreign policy, national and supranational regulatory processes, international organizations, and through working with other industries. Analysis of such strategies is a precondition for fully understanding the nature and extent of tobacco industry influence and for promoting policy coherence between global health concerns and trade, foreign policy and development agendas. Furthermore, the US and many other countries that have implemented wide-ranging tobacco control programs still face considerable difficulties in controlling their tobacco epidemics. Research that addresses ongoing developments in tobacco industry structure and tactics is, therefore, increasingly required to inform more innovative policy developments that will be essential to effectively addressing tobacco use in the future. This proposed project aims to: 1. Contribute to the methodological development of document-based research, examine continuity and change in corporate strategy, and develop a taxonomy of tobacco industry strategies to shape policy. 2. Examine the implications of trade agreements for tobacco control and global health. 3. Analyze the health implications for tobacco control of industry efforts to introduce wide ranging regulatory reforms and to influence non-governmental organizations and examine broader engagement in global health initiatives.

Public Health Relevance

National and international efforts to reduce the damage from tobacco use risk being undermined by tobacco companies and recent developments in global governance which provide opportunities for tobacco companies to expand sales and influence policy. Yet understanding of how tobacco companies engage with economic, foreign policy and development agendas, and take advantage of and influence trade agreements, regulatory processes and civil society organizations in order to advance their interests remains limited. This project will address these research gaps and, by examining developments in tobacco industry structure and tactics, will inform the development of innovative policy options essential to effectively address tobacco use.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Community Influences on Health Behavior (CIHB)
Program Officer
Kaufman, Annette R
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Bath
United Kingdom
Zip Code
BA2 7-AY
Peeters, Silvy; Gilmore, Anna B (2015) Understanding the emergence of the tobacco industry's use of the term tobacco harm reduction in order to inform public health policy. Tob Control 24:182-9
Branston, J Robert; Gilmore, Anna B (2014) The case for Ofsmoke: the potential for price cap regulation of tobacco to raise ýý500 million per year in the UK. Tob Control 23:45-50
Gilmore, Anna B; Rowell, Andy; Gallus, Silvano et al. (2014) Towards a greater understanding of the illicit tobacco trade in Europe: a review of the PMI funded 'Project Star' report. Tob Control 23:e51-61
Collin, Jeff; Johnson, Emma; Officer, House et al. (2014) Government support for alcohol industry: promoting exports, jeopardising global health? BMJ 348:g3648
Ulucanlar, Selda; Fooks, Gary J; Hatchard, Jenny L et al. (2014) Representation and misrepresentation of scientific evidence in contemporary tobacco regulation: a review of tobacco industry submissions to the UK Government consultation on standardised packaging. PLoS Med 11:e1001629
Rowell, A; Evans-Reeves, K; Gilmore, A B (2014) Tobacco industry manipulation of data on and press coverage of the illicit tobacco trade in the UK. Tob Control 23:e35-43
Gallus, Silvano; Lugo, Alessandra; Fernandez, Esteve et al. (2014) Support for a tobacco endgame strategy in 18 European countries. Prev Med 67:255-8
Plotnikova, Evgeniya; Hill, Sarah E; Collin, Jeff (2014) The 'diverse, dynamic new world of global tobacco control'? An analysis of participation in the Conference of the Parties to the WHO Framework Convention on Tobacco Control. Tob Control 23:126-32
Costa, Hélia; Gilmore, Anna B; Peeters, Silvy et al. (2014) Quantifying the influence of the tobacco industry on EU governance: automated content analysis of the EU Tobacco Products Directive. Tob Control 23:473-8
Gallus, Silvano; Lugo, Alessandra; Ghislandi, Simone et al. (2014) Roll-your-own cigarettes in Europe: use, weight and implications for fiscal policies. Eur J Cancer Prev 23:186-92

Showing the most recent 10 out of 21 publications